The MIMS website is updated constantly, providing the latest prescribing information along with essential prescribing news and resources.
MIMS quarterly print publication
The MIMS book is published every quarter and is sent free of charge to the practice addresses of all UK-based GPs who complete our online registration form .
If you have already registered and need to change your mailing address, please call 0845 136 93 16 or email email@example.com including your name, surgery address and GMC number.
Other relevant healthcare professionals may subscribe to MIMS by emailing firstname.lastname@example.org .
The mobile-friendly online version of MIMS contains additional resources and registration provides GPs with free access to the drug database and full range of prescribing resources.
MIMS online content
- MIMS drug database : search up-to-date drug information for over 3000 branded and generic products, including indications, doses, side effects, interactions, contraindications and warnings. Browse drugs by therapeutic area or manufacturer or use the search box to extend your search to tables, guidelines and news.
: the latest updates affecting prescribing including new drugs, product changes and guideline updates.
- Drug shortages tracker : constantly updated list of products reported to be out of stock in the UK, designed to help you avoid prescribing products that are out of stock.
- Quick reference tables : exclusive clinical and comparison tables for quick look-up, including HRT preparations and antidepressant switching advice.
- Clinical guideline summaries : at-a-glance synopses of national treatment guidelines.
- Visual guides to diabetes and respiratory devices : pictorial resources to help you compare and recommend suitable options.
Further information about MIMS
GPs can now prescribe antiviral medicines for flu prophylaxis and treatment at NHS expense, following an increase in infections in the community.
Voke, a new nicotine inhaler, is available to prescribe for patients who want to quit smoking.
Triple therapy with a long-acting muscarinic antagonist (LAMA), long-acting beta agonist (LABA) and inhaled corticosteroid (ICS) is associated with a lower risk of exacerbations than single or dual inhaled therapy in patients with stable COPD, according to a meta-analysis of 219 trials.
Prescribers are being advised to prioritise supplies of certain medications and to consider switching patients to unlicensed alternatives in some cases, as more than 100 drugs remain out of stock.
In a case reported in the Archives of Disease in Childhood, a teenage boy in Nottingham developed life-threatening hypersensitivity pneumonitis after using e-cigarettes.
- Salaried GP and Maternity Locum Postions Salford Care Centres Manchester, Greater Manchester
- GP Partner Position Thurso & Halkirk Medical Practice Thurso, Highland
- Salaried GP – 2/3 sessions Liphook Village Surgery Liphook, Hampshire
- Part time GP Partner Rotherham Road Medical Centre Barnsley, South Yorkshire
- Salaried GP with a view to partnership Radnor House Surgery Ascot, Berkshire